Diamond Capital (Taiwan)

Diamond Capital (Taiwan) Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 2
  • Investments
  • 13
  • Portfolio
  • 8
  • Exits
  • 5

Diamond Capital (Taiwan) General Information


Diamond Capital (Taiwan) is a venture capital firm dedicated to biotechnology innovation, managing assets worth over 260 million dollars. It focuses on the healthcare and biotechnology related industry, including new drugs development, medical devices, health supplements, diagnostics, healthcare retailing channels and innovative healthcare services. The firm is based in Taipei, Taiwan and was founded in 2013.

Contact Information

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Taipei
  • Taiwan

Diamond Capital (Taiwan) Investments (13)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
EyeYon Medical 21-Mar-2017 Later Stage VC 00.00 Therapeutic Devices Generating Revenue
0000000 0000000 00 01-Oct-2016 00000 00000 Therapeutic Devices Generating Revenue
0000000 25-Nov-2015 00000 00000 00.00 Surgical Devices Generating Revenue
00000 000000 22-Sep-2015 00000 00000 Clinics/Outpatient Services Generating Revenue
00000 0000000 27-Aug-2015 00000 00000 0000 Diagnostic Equipment Pre-Clinical Trials
0000000 00000000 01-Jan-2015 00000 00000 000.00 Biotechnology Generating Revenue
00 000000 0000000 01-Dec-2014 00000 00000 Outcome Management (Healthcare) Out of Business
00000000 000000000 19-Aug-2014 0000 00.00 Drug Discovery Generating Revenue/Not Profitable
Century Hill Enterprises 01-Jun-2014 Early Stage VC Drug Discovery Out of Business
Swissray 01-Jan-2013 PIPE Diagnostic Equipment Generating Revenue/Not Profitable
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Diamond Capital (Taiwan) Exits (5)

To view Diamond Capital (Taiwan)‘s complete exit history, request access »
Company Name Exit Date Exit Type Exit Size
3D Global Biotech 01-Apr-2018 Out of Business
0000000 21-Nov-2017 000000000000000000 0000
000 000000 27-Sep-2017 000
Synovel Sciences 01-Mar-2017 Merger/Acquisition
Century Hill Enterprises Out of Business

Diamond Capital (Taiwan) Co-Investors (4)

To view Diamond Capital (Taiwan)‘s complete co-investor history, request access »
Name With Exits Lead Partner Series Industry
Gauss Group 1 Series chart Industry bar
Pontifax Venture Capital 0 Series chart Industry bar
Rimonci Capital 0 Series chart Industry bar
Triventures 0 Series chart Industry bar